|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sipponen P and Correa P: Delayed rise in
incidence of gastric cancer in females results in unique sex ratio
(M/F) pattern: Etiologic hypothesis. Gastric Cancer. 5:213–219.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Camargo MC, Goto Y, Zabaleta J, Morgan DR,
Correa P and Rabkin CS: Sex hormones, hormonal interventions and
gastric cancer risk: A meta-analysis. Cancer Epidemiol Biomarkers
Prev. 21:20–38. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lindblad M, Ye W, Rubio C and Lagergren J:
Estrogen and risk of gastric cancer: A protective effect in a
nationwide cohort study of patients with prostate cancer in Sweden.
Cancer Epidemiol Biomarkers Prev. 13:2203–2207. 2004.PubMed/NCBI
|
|
7
|
Ryu WS, Kim JH, Jang YJ, Park SS, Um JW,
Park SH, Kim SJ, Mok YJ and Kim CS: Expression of estrogen
receptors in gastric cancer and their clinical significance. J Surg
Oncol. 106:456–461. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rahman Ur MS and Cao J: Estrogen receptors
in gastric cancer: Advances and perspectives. World J
Gastroenterol. 22:2475–2482. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Deng H, Huang X, Fan J, Wang L, Xia Q,
Yang X, Wang Z and Liu L: A variant of estrogen receptor-alpha,
ER-alpha36 is expressed in human gastric cancer and is highly
correlated with lymph node metastasis. Oncol Rep. 24:171–176.
2010.PubMed/NCBI
|
|
10
|
Wang X, Deng H, Zou F, Fu Z, Chen Y, Wang
Z and Liu L: ER-α36-mediated gastric cancer cell proliferation via
the c-Src pathway. Oncol Lett. 6:329–335. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Z, Zhang X, Shen P, Loggie BW, Chang
Y and Deuel TF: Identification, cloning, and expression of human
estrogen receptor-alpha36, a novel variant of human estrogen
receptor-alpha66. Biochem Biophys Res Commun. 336:1023–1027. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang ZY and Yin L: Estrogen receptor
alpha-36 (ER-α36): A new player in human breast cancer. Mol Cell
Endocrinol 418 Pt. 3:193–206. 2015. View Article : Google Scholar
|
|
13
|
Wang Z, Zhang X, Shen P, Loggie BW, Chang
Y and Deuel TF: A variant of estrogen receptor-{alpha},
hER-{alpha}36: Transduction of estrogen- and antiestrogen-dependent
membrane-initiated mitogenic signaling. Proc Natl Acad Sci USA.
103:9063–9068. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang X, Huang X, Fu Z, Zou F, Li Y, Wang Z
and Liu L: Biphasic ER-α36-mediated estrogen signaling regulates
growth of gastric cancer cells. Int J Oncol. 45:2325–2330. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shi L, Dong B, Li Z, Lu Y, Ouyang T, Li J,
Wang T, Fan Z, Fan T, Lin B, et al: Expression of ER-{alpha}36, a
novel variant of estrogen receptor {alpha}, and resistance to
tamoxifen treatment in breast cancer. J Clin Oncol. 27:3423–3429.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee AS: Glucose-regulated proteins in
cancer: Molecular mechanisms and therapeutic potential. Nat Rev
Cancer. 14:263–276. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Z and Li Z: Glucose regulated protein
78: A critical link between tumor microenvironment and cancer
hallmarks. Biochim Biophys Acta. 1826:13–22. 2012.PubMed/NCBI
|
|
18
|
Lee AS: GRP78 induction in cancer:
Therapeutic and prognostic implications. Cancer Res. 67:3496–3499.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miao YR, Eckhardt BL, Cao Y, Pasqualini R,
Argani P, Arap W, Ramsay RG and Anderson RL: Inhibition of
established micrometastases by targeted drug delivery via cell
surface-associated GRP78. Clin Cancer Res. 19:2107–2116. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng HC, Takahashi H, Li XH, Hara T,
Masuda S, Guan YF and Takano Y: Overexpression of GRP78 and GRP94
are markers for aggressive behavior and poor prognosis in gastric
carcinomas. Hum Pathol. 39:1042–1049. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang J, Jiang Y, Jia Z, Li Q, Gong W,
Wang L, Wei D, Yao J, Fang S and Xie K: Association of elevated
GRP78 expression with increased lymph node metastasis and poor
prognosis in patients with gastric cancer. Clin Exp Metastasis.
23:401–410. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cheng CC, Lu N, Peng CL, Chang CC, Mai FD,
Chen LY, Liao MH, Wang WM and Chang J: Targeting to overexpressed
glucose-regulated protein 78 in gastric cancer discovered by 2D
DIGE improves the diagnostic and therapeutic efficacy of
micelles-mediated system. Proteomics. 12:2584–2597. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Luvsandagva B, Nakamura K, Kitahara Y,
Aoki H, Murata T, Ikeda S and Minegishi T: GRP78 induced by
estrogen plays a role in the chemosensitivity of endometrial
cancer. Gynecol Oncol. 126:132–139. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fernandez PM, Tabbara SO, Jacobs LK,
Manning FC, Tsangaris TN, Schwartz AM, Kennedy KA and Patierno SR:
Overexpression of the glucose-regulated stress gene GRP78 in
malignant but not benign human breast lesions. Breast Cancer Res
Treat. 59:15–26. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fu Z, Deng H, Wang X, Yang X, Wang Z and
Liu L: Involvement of ER-α36 in the malignant growth of gastric
carcinoma cells is associated with GRP94 overexpression.
Histopathology. 63:325–333. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hou J, Deng M, Li X, Liu W, Chu X, Wang J,
Chen F and Meng S: Chaperone gp96 mediates ER-α36 cell membrane
expression. Oncotarget. 6:31857–31867. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kang L, Guo Y, Zhang X, Meng J and Wang
ZY: A positive cross-regulation of HER2 and ER-α36 controls ALDH1
positive breast cancer cells. J Steroid Biochem Mol Biol.
127:262–268. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Avila MF, Cabezas R, Torrente D, Gonzalez
J, Morales L, Alvarez L, Capani F and Barreto GE: Novel
interactions of GRP78: UPR and estrogen responses in the brain.
Cell Biol Int. 37:521–532. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang XM, Huang X, Fu ZQ, Zou F, Zhang SK
and Wang ZY: Construction of lentiviral vector-mediated siRNA
knockdown of ER-α36 and its action on gastric cancer cell growth.
Chin J Pathophysiol. 12:2113–2119. 2014.(In Chinese).
|
|
30
|
Wang M, Pan JY, Song GR, Chen HB, An LJ
and Qu SX: Altered expression of estrogen receptor alpha and beta
in advanced gastric adenocarcinoma: Correlation with prothymosin
alpha and clinicopathological parameters. Eur J Surg Oncol.
33:195–201. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Takano N, Iizuka N, Hazama S, Yoshino S,
Tangoku A and Oka M: Expression of estrogen receptor-alpha and
-beta mRNAs in human gastric cancer. Cancer Lett. 176:129–135.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gan L, He J, Zhang X, Zhang YJ, Yu GZ,
Chen Y, Pan J, Wang JJ and Wang X: Expression profile and
prognostic role of sex hormone receptors in gastric cancer. BMC
Cancer. 12:5662012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kang JM, Park S and Kim SJ, Kim H, Lee B,
Kim J, Park J, Kim ST, Yang HK, Kim WH and Kim SJ: KIAA1324
suppresses gastric cancer progression by inhibiting the oncoprotein
GRP78. Cancer Res. 75:3087–3097. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Beurel E and Jope RS: The paradoxical pro-
and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic
apoptosis signaling pathways. Prog Neurobiol. 79:173–189. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
McCubrey JA, Steelman LS, Bertrand FE,
Davis NM, Sokolosky M, Abrams SL, Montalto G, D'Assoro AB, Libra M,
Nicoletti F, et al: GSK-3 as potential target for therapeutic
intervention in cancer. Oncotarget. 5:2881–2911. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dembowy J, Adissu HA, Liu JC, Zacksenhaus
E and Woodgett JR: Effect of glycogen synthase kinase-3
inactivation on mouse mammary gland development and oncogenesis.
Oncogene. 34:3514–3526. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Grisouard J, Medunjanin S, Hermani A,
Shukla A and Mayer D: Glycogen synthase kinase-3 protects estrogen
receptor alpha from proteasomal degradation and is required for
full transcriptional activity of the receptor. Mol Endocrinol.
21:2427–2439. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Song L, De Sarno P and Jope RS: Central
role of glycogen synthase kinase-3beta in endoplasmic reticulum
stress-induced caspase-3 activation. J Biol Chem. 277:44701–44708.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu ZC, Fu ZQ, Song J, Zhang JY, Wei YP,
Chu J, Han L, Qu N, Wang JZ and Tian Q: Bip enhanced the
association of GSK-3β with tau during ER stress both in vivo and in
vitro. J Alzheimers Dis. 29:727–740. 2012.PubMed/NCBI
|
|
40
|
Lau MY, Han H, Hu J and Ji C: Association
of cyclin D and estrogen receptor α36 with hepatocellular adenomas
of female mice under chronic endoplasmic reticulum stress. J
Gastroenterol Hepatol. 28:576–583. 2013. View Article : Google Scholar : PubMed/NCBI
|
